Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Okuyama, Yoshiki  [Clear All Filters]
2024
Kurihara K, Sadato D, Najima Y, Hirama C, Haraguchi K, Kato K, Kondo K, Sadaga Y, Kato C, Sakai S, et al. [FLT3-ITD mutation-positive acute myeloid leukemia undergoing clonal transition with PTPN11 mutation at relapse]. Rinsho Ketsueki. 2024;65(2):63-68.
Nishijima A, Shingai N, Ohta A, Suda K, Omoto K, Ishida S, Yoshioka K, Kurosawa S, Hino Y, Senoo Y, et al. [Kidney transplantation for end-stage renal disease after third allogeneic hematopoietic stem cell transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia]. Rinsho Ketsueki. 2024;65(1):7-12.
Kambara Y, Sadato D, Toya T, Honda A, Kato S, Hirama C, Haraguchi K, Shimizu H, Najima Y, Kobayashi T, et al. Recurrent DDX41 mutation in very late relapse after allogeneic stem cell transplantation. Leukemia. 2024.
Koi S, Shimizu H, Sadaga Y, Kondo K, Kato C, Sakai S, Kambara Y, Konuma R, Atsuta Y, Shimabukuro M, et al. [Ruptured mycotic cerebral aneurysm in an adult T-cell leukemia/lymphoma patient undergoing allogeneic stem cell transplantation]. Rinsho Ketsueki. 2024;65(2):84-89.
2023
Shingai N, Mizumaki H, Najima Y, Yamada Y, Tran DCao, Haraguchi K, Toya T, Okuyama Y, Doki N, Nannya Y, et al. Case report: Immune pressure on hematopoietic stem cells can drastically expand glycosylphosphatidylinositol-deficient clones in paroxysmal nocturnal hemoglobinuria. Front Immunol. 2023;14:1329403.
Jo T, Henzan T, Tomizawa D, Yoshihara S, Kahata K, Yamada-Fujiwara M, Okuyama Y, Shiba N, Fujii K, Umezawa Y, et al. [Manufacturing results of tisagenlecleucel for acute lymphoblastic leukemia: a survey by the CAR-T cell therapy taskforce of the Japan Society of Transfusion Medicine and Cell Therapy]. Rinsho Ketsueki. 2023;64(5):331-337.
Morita Y, Yagi Y, Kanemasa Y, Sasaki Y, Ishimine K, Hayashi Y, Mino M, Ohigashi A, Tamura T, Nakamura S, et al. [Polatuzumab vedotin, bendamustine, and rituximab in patients with relapsed/refractory diffuse large B-cell lymphoma, including the outcome as a bridging treatment to CAR-T cell therapy or allogeneic hematopoietic stem cell transplant]. Rinsho Ketsueki. 2023;64(7):586-595.
Jo T, Yoshihara S, Okuyama Y, Fujii K, Henzan T, Kahata K, Yamazaki R, Takeda W, Umezawa Y, Fukushima K, et al. Risk factors for CAR-T cell manufacturing failure among DLBCL patients: A nationwide survey in Japan. Br J Haematol. 2023.
2021
Yagi Y, Kanemasa Y, Ohigashi A, Morita Y, Tamura T, Nakamura S, Otsuka Y, Kishida Y, Kageyama A, Shimizuguchi T, et al. Chimeric antigen receptor T-cell therapy following autologous transplantation for secondary central nervous system lymphoma: A case report. Medicine (Baltimore). 2021;100(44):e27733.
2020
Yokohama A, Okuyama Y, Ueda Y, Itoh M, Fujiwara S-I, Hasegawa Y, Nagai K, Arakawa K, Miyazaki K, Makita M, et al. Differences among hemoglobin thresholds for red blood cell transfusions in patients with hematological diseases in teaching hospitals: a real world data in Japan. Int J Hematol. 2020.
Harada Y, Shingai N, Ding Y, Sadato D, Hayashi Y, Yamaguchi M, Okuyama Y, Shimoyama T, Ohashi K, Harada H. Gene Rearrangements of MLL and RUNX1 Sporadically Occur in Normal CD34 Cells Under Cytokine Stimulation. Cancer Sci. 2020.
Ikeda K, Ohto H, Yamada-Fujiwara M, Okuyama Y, Fujiwara S-I, Muroi K, Mori T, Kasama K, Kanamori H, Iseki T, et al. Hematopoietic cell infusion-related adverse events in pediatric/small recipients in a prospective/multicenter study. Transfusion. 2020.
2015
Ikegawa S, Doki N, Kurosawa S, Yamaguchi T, Sakaguchi M, Harada K, Yamamoto K, Hino Y, Shingai N, Senoo Y, et al. CD25 expression on residual leukemic blasts at the time of allogeneic hematopoietic stem cell transplantation predicts relapse in patients with acute myeloid leukemia without complete remission. Leuk Lymphoma. 2015:1-14.